Market revenue in 2020 | USD 13,341.9 million |
Market revenue in 2028 | USD 17,024.8 million |
Growth rate | 3.1% (CAGR from 2020 to 2028) |
Largest segment | Consumables |
Fastest growing segment | Consumables |
Historical data covered | 2016 - 2019 |
Base year for estimation | 2020 |
Forecast period covered | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Consumables, Services |
Key market players worldwide | Abbott Laboratories, Thermo Fisher Scientific Inc, Koninklijke Philips NV, BD, BioMerieux SA, Bio-Rad Laboratories Inc, QuidelOrtho Corp, Siemens Healthineers AG ADR, Danaher Corp, Qiagen NV, Roche |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious respiratory disease diagnostics market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 64.75% in 2020. Horizon Databook has segmented the North America infectious respiratory disease diagnostics market based on instruments, consumables, services covering the revenue growth of each sub-segment from 2016 to 2028.
North America is the largest region in the market, owing to increasing adoption of diagnostic products due to its high accuracy, sensitivity, and specificity. Increasing requirement of tests for diagnosis of diseases, such as tuberculosis, RSV, influenza A & B, and COVID-19 is expected to drive market growth.
Increasing number of strategic partnerships among manufacturers of testing kits and In Vitro Diagnostics (IVD) companies for the development of novel techniques makes North America a lucrative market for infectious respiratory disease diagnostics.
Favorable government initiatives and reimbursement policies are likely to drive market growth. The New Technology Add-on Payment (NTAP) program has been introduced by the CMS to reduce financial losses for hospitals.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America infectious respiratory disease diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into North America infectious respiratory disease diagnostics market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account